Channelopathies: Their Contribution to Our Knowledge About Voltage-Gated Ion Channels
نویسنده
چکیده
Qian, L. A. Bayewitch, A. M. Cohen, C. J. Herrera, S. S.-F. Hu, T. B. Kramer, F. D. Lott, F. H. Martin, G. F. Pierce, L. Simonet, and C. L. Farrell. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Nat/. Acad. Sci. USA 92: 4051-4055, 1995. 3. Crooke, S. T. Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEBj. 7: 533-539, 1993. 4. Gyurko, R.,. D. Wielbo, and M. I. Phillips. Antisense inhibition of AT, receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul. Pept. 49:167-174, 1993. 5. Meng, H.-B., D. Wielbo, R. Gyurko, and M. I. Phillips. AT, receptor mRNA antisense oligonucleotide inhibits central angiotensin induced thirst and vasopressin. Regul. Pept.54: 543-551, 1994. 6. Morishita, R., G. H. Gibbons, K. E. Ellison, M. Nakajima, L. Zhang, Y. Kaneda, T. Ogihara, and V. J. Dzau. Single intraluminal delivery of antisense cdc2 kinase and proliferating-ccl I nuclear antigen ol igonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Nat/. Acad. Sci. USA 90: 8474-8478, 1993. 7. Phillips, M. I. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension 29: 177-l 87, 1997. 8. Phillips, M. I., D. Wielbo, and R. Gyurko. Antisense inhibition of hypertension: a new strategy for reninangiotensin candidate genes. Kidney Int. 46: 15541556,1994. 9. Sakai, R. R., P. F. He, X. D. Yang, L. Y. Ma, Y. F. Guo, J. J. Reilly, C. N. Moga, and S. J. Fluharty, Intracerebroventricular administration of AT, receptor antisense oligonucleotide inhibits the behavioral actions of angiotensin II. /. Neurochem. 62: 2053-2056, 1994. 10. Simons, M., E. R. Edelman, J.-L. DeKeyser, R. Langer, and R. D. Rosenberg. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359: 67-70, 1992. 11. Stein, C. A. Phosphorothioate antisense oligodeoxynucleotides: questions of specificity. Trends Biotechnol. 14:147-149,1996. 12. Tomita, N., R. Morishita, J. Higaki, Y. Kaneda, H. Mikami, and T. Ogihara. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotide against rat angiotensinogen. Hypertension 26: 131-136, 1995. 13. Wagner, R. W. The state of the art in antisense research. NatureMed. 1:1116-1118,1995. 14. Wahlestedt, C., E. M. Pith, G. F. Koob, F. Yee, and M. Heilig. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528-531,1993. 15. Wielbo, D., C. Sernia, R. Gyurko, and M. I. Phillips. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension 25: 314-329, 1994.
منابع مشابه
Inherited disorders of voltage-gated sodium channels.
A variety of inherited human disorders affecting skeletal muscle contraction, heart rhythm, and nervous system function have been traced to mutations in genes encoding voltage-gated sodium channels. Clinical severity among these conditions ranges from mild or even latent disease to life-threatening or incapacitating conditions. The sodium channelopathies were among the first recognized ion chan...
متن کاملA High Throughput Screening Technology-Overcoming Bottlenecks in Ion Channel Drug Targets
Ion Channels as therapeutic targets: Ion channels are transmembrane proteins that allow the formation of a concentration gradient between the extracellular and intracellular contents. Three major types of gated ion channels: (1) Ligand gated, (2) Mechanically gated and (3) Voltage gated channels are known to play pivotal roles in a variety of cellular processes within the human body and have be...
متن کاملChannelopathies: ion channel defects linked to heritable clinical disorders.
Electrical signals are critical for the function of neurones, muscle cells, and cardiac myocytes. Proteins that regulate electrical signalling in these cells, including voltage gated ion channels, are logical sites where abnormality might lead to disease. Genetic and biophysical approaches are being used to show that several disorders result from mutations in voltage gated ion channels. Underst...
متن کاملReview article Channelopathies: ion channel defects linked to heritable clinical disorders
Electrical signals are critical for the function of neurones, muscle cells, and cardiac myocytes. Proteins that regulate electrical signalling in these cells, including voltage gated ion channels, are logical sites where abnormality might lead to disease. Genetic and biophysical approaches are being used to show that several disorders result from mutations in voltage gated ion channels. Underst...
متن کاملVoltage-gated ion channels and hereditary disease.
By the introduction of technological advancement in methods of structural analysis, electronics, and recombinant DNA techniques, research in physiology has become molecular. Additionally, focus of interest has been moving away from classical physiology to become increasingly centered on mechanisms of disease. A wonderful example for this development, as evident by this review, is the field of i...
متن کاملChannelopathies and dendritic dysfunction in fragile X syndrome.
Dendritic spine abnormalities and the metabotropic glutamate receptor theory put the focus squarely on synapses and protein synthesis as the cellular locus of fragile X syndrome. Synapses however, are only partly responsible for information processing in neuronal networks. Neurotransmitter triggered excitatory postsynaptic potentials (EPSPs) are shaped and integrated by dendritic voltage-gated ...
متن کامل